These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30089263)

  • 1. Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function.
    Levy AD; Xiao X; Shaw JE; Sudarsana Devi SP; Katrancha SM; Bennett AM; Greer CA; Howe JR; Machida K; Koleske AJ
    Cell Rep; 2018 Aug; 24(6):1523-1535. PubMed ID: 30089263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF contributes to the development of neuropathic pain by induction of spinal long-term potentiation via SHP2 associated GluN2B-containing NMDA receptors activation in rats with spinal nerve ligation.
    Ding X; Cai J; Li S; Liu XD; Wan Y; Xing GG
    Neurobiol Dis; 2015 Jan; 73():428-51. PubMed ID: 25447233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noonan syndrome-associated SHP2 mutation differentially modulates the expression of postsynaptic receptors according to developmental maturation.
    Oh JY; Rhee S; Silva AJ; Lee YS; Kim HK
    Neurosci Lett; 2017 May; 649():41-47. PubMed ID: 28366775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.
    De Rocca Serra-Nédélec A; Edouard T; Tréguer K; Tajan M; Araki T; Dance M; Mus M; Montagner A; Tauber M; Salles JP; Valet P; Neel BG; Raynal P; Yart A
    Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4257-62. PubMed ID: 22371576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish.
    Bonetti M; Paardekooper Overman J; Tessadori F; Noël E; Bakkers J; den Hertog J
    Development; 2014 May; 141(9):1961-70. PubMed ID: 24718990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome.
    Krenz M; Gulick J; Osinska HE; Colbert MC; Molkentin JD; Robbins J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18930-5. PubMed ID: 19017799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PZR coordinates Shp2 Noonan and LEOPARD syndrome signaling in zebrafish and mice.
    Paardekooper Overman J; Yi JS; Bonetti M; Soulsby M; Preisinger C; Stokes MP; Hui L; Silva JC; Overvoorde J; Giansanti P; Heck AJ; Kontaridis MI; den Hertog J; Bennett AM
    Mol Cell Biol; 2014 Aug; 34(15):2874-89. PubMed ID: 24865967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects.
    Solman M; Blokzijl-Franke S; Piques F; Yan C; Yang Q; Strullu M; Kamel SM; Ak P; Bakkers J; Langenau DM; Cavé H; den Hertog J
    Elife; 2022 May; 11():. PubMed ID: 35535491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner.
    Zheng H; Yu WM; Waclaw RR; Kontaridis MI; Neel BG; Qu CK
    Sci Signal; 2018 Mar; 11(522):. PubMed ID: 29559584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHP2 mutations induce precocious gliogenesis of Noonan syndrome-derived iPSCs during neural development in vitro.
    Ju Y; Park JS; Kim D; Kim B; Lee JH; Nam Y; Yoo HW; Lee BH; Han YM
    Stem Cell Res Ther; 2020 Jun; 11(1):209. PubMed ID: 32493428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the Molecular Basis of the Noonan Syndrome-Causing Mutation T42A of SHP2.
    Toto A; Malagrinò F; Visconti L; Troilo F; Gianni S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase.
    Miura K; Wakayama Y; Tanino M; Orba Y; Sawa H; Hatakeyama M; Tanaka S; Sabe H; Mochizuki N
    Oncogene; 2013 Nov; 32(45):5292-301. PubMed ID: 23318428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Noonan syndrome-associated D61G variant of the protein tyrosine phosphatase SHP2 prevents synaptic down-scaling.
    Lu W; Ai H; Xue F; Luan Y; Zhang B
    J Biol Chem; 2020 Jul; 295(29):10023-10031. PubMed ID: 32499374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental SHP2 dysfunction underlies cardiac hypertrophy in Noonan syndrome with multiple lentigines.
    Lauriol J; Cabrera JR; Roy A; Keith K; Hough SM; Damilano F; Wang B; Segarra GC; Flessa ME; Miller LE; Das S; Bronson R; Lee KH; Kontaridis MI
    J Clin Invest; 2016 Aug; 126(8):2989-3005. PubMed ID: 27348588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth.
    Tajan M; Pernin-Grandjean J; Beton N; Gennero I; Capilla F; Neel BG; Araki T; Valet P; Tauber M; Salles JP; Yart A; Edouard T
    Hum Mol Genet; 2018 Jul; 27(13):2276-2289. PubMed ID: 29659837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase SHP2/PTPN11 mistargeting as a consequence of SH2-domain point mutations associated with Noonan Syndrome and leukemia.
    Müller PJ; Rigbolt KT; Paterok D; Piehler J; Vanselow J; Lasonder E; Andersen JS; Schaper F; Sobota RM
    J Proteomics; 2013 Jun; 84():132-47. PubMed ID: 23584145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of synaptic GluN2B subunit-containing N-methyl-D-aspartate receptors: a physiological brake on CA1 neuron α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal.
    Shen G; Tietz EI
    J Pharmacol Exp Ther; 2011 Jan; 336(1):265-73. PubMed ID: 20935233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of SHP2 (PTPN11) in glycoprotein VI-dependent thrombus formation: Improved platelet responsiveness by the allosteric drug SHP099 in Noonan syndrome patients.
    Fernández DI; Diender M; Hermida-Nogueira L; Huang J; Veiras S; Henskens YMC; Te Loo MWM; Heemskerk JWM; Kuijpers MJE; García Á
    Thromb Res; 2023 Aug; 228():105-116. PubMed ID: 37302266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.